DETTE Changement Date
Agenus USD 35.54M 2.34M 2025-03
AstraZeneca USD 32.24B 1.68B 2026-06
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Celldex Therapeutics USD 4.9M 3M 2026-06
Eisai JPY 254.94B 68.86B 2026-09
Merck USD 53.91B 4.79B 2026-06
Northwest Biotherapeutics USD 32.94M 6.93M 2023-09
Pfizer USD 62.67B 523M 2026-09
Plus Therapeutics USD 3.98M 372K 2023-12
Roche Holding CHF 33.03B 1.41B 2025-06